Fagron US announces stability data on LETS GEL KIT™ for rapid topical anesthesia

Tue, 11/28/2017
New study supports extended beyond use dating in Fagron unit dose syringe

Fagron US announces 90 day beyond-use-dating (BUD) study results for their industry leading LETS GEL KIT™, a rapid topical anesthesia convenience pack, when stored in Fagron 3 mL unit dose syringes. New LETS GEL KIT™, launched summer 2017, features SuturaGel™, a specially formulated gel to minimize medication run-off. Included in this easy-to-use convenience pack are pre-weighed active ingredients--Lidocaine Hydrochloride, Epinephrine Bitartrate, Tetracaine Hydrochloride, Sodium Metabisulfite, topical syringes, and SuturaGel™.

Used for pain prevention when suturing, pharmacists now can reliably prepare up to 33 unit-doses with 90 days BUD when compounding LETS GEL KIT™. For a video demonstration on how easy Fagron made LETS GEL KIT™ for healthcare providers to prepare, visit: https://www.youtube.com/watch?v=3i_YiRMYmrA&feature=youtu.be.

"We are delighted with our BUD study results that were performed at an independent laboratory,” stated Ronaldo Steentjes, General Manager of Fagron US. "Our investment in research and development further represents Fagron’s commitment to provide quality, proven products to the US market and abroad.”

Fagron US routinely introduces innovative products to the market based on research completed in their own R&D center.